Proteus infection pathophysiology

Jump to navigation Jump to search

Proteus infection Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Classification

Causes

Screening

Differentiating Proteus infection from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Proteus infection On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Proteus infection

All Images
infection X-ray X-rays
infection Ultrasound Echo & Ultrasound
infection CT CT Images
infection MRI MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Proteus infection

CDC on Proteus infection

Proteus infection in the news

Blogs on Proteus infection

Directions to Hospitals Treating Proteus infection

Risk calculators and risk factors for Proteus infection

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Proteus is part of the normal human gastrointestinal flora and is usually associated with development of urinary tract infections (most common), pnuemonia, and local wound infections by self-contamination. Following self-contamination, Proteus accesses the urinary tract through the urethra and overproduces flagella (transforms from swimmer to swarmer) to ascend in a retrograde manner to the upper urinary tract. In the bladder, Proteus uses fimbriae and adhesins to bind to mucosal surfaces. To avoid host defenses, Proteus produces virulence factors, such as IgA-degrading protease, hemolysin, and urease. As urease is produced, urea is hydrolyzed to ammonia and carbon dioxide, resulting in the increase in the local pH of the urinary tract and precipitation of magnesium and calcium ions. As ions precipitate, strutive (magnesium ammonium phosphate) stones form and epxand, giving Proteus the capacity to sequester within the stone cavities and to protect itself against the host defenses and antimicrobial agents.

Pathophysiology

Colonization

  • Proteus is part of the normal human gastrointestinal flora and is usually associated with development of urinary tract infections (most common), pnuemonia, and local wound infections by self-contamination.
  • Following self-contamination, Proteus accesses the urinary tract through the urethra and uses flagella to ascend in a retrograde manner to the upper urinary tract.[1]
  • During the motility process, the production of flagella markedly increases, and the organism changes from a single-cell, rod-shaped form (swimmer) to a multi-cell, elongated-form (swarmer).[2][1]
  • In the bladder, Proteus uses fimbriae and adhesins to bind to mucosal surfaces:[1]
  • Mannose-resistant fimbriae (MRF)
  • P. mirabilis fimbriae (PMF)
  • Ambient temperature fimbiae
  • Non-agglutinating fimbiae
  • P-like pilus

Evasion of Host Defenses

  • There are four mechanisms by which Proteus can use to evade the host defenses:[1][2]
  • Production of an IgA-degrading protease which functions to cleave the secretory IgA.
  • Expression of flagellin to synthesize flagella that provides the characteristic swarming motility of Proteus.
  • Expression of the MR/P fimbriae
  • Production of urease (increases pH) to provide an adequate medium for bacterial growth. Urease production is also associated with stone formation in the kidneys and the bladder.[3]
Production of hemolysin, a cytotoxin involved in injury of host epithelial cells are known to cause damage to host epithelial cells. As mentioned above, urease can damage host epithelial cells through the formation of stones. Hemolysin damages cells

Formation of Stones / Staghorn Calculi

  • Proteus produces urease, which catalyzes the hydrolysis of urea tot ammonia and carbon dioxide.[4]
  • The ammonia results in an increase in the local pH of the urinary tract, resulting in the precipitation of magnesium and calcium ions and subsequent formation of struvite (composed of magnesium ammonioum phosphate) and carbonate hydroxyapatite stones.[4][5][3]
  • Proteus is able to sequester in the stone cavities and replicate while avoiding host defenses and therapeutic agents.[5]
  • As the infection persists or as the human host is re-infected, the existing stone expands and occasionally blocks the urinary tract completely. Large stones are referred to as Staghorn calculi, given their resemblance to the horns of a stag (adult male deer).

References

  1. 1.0 1.1 1.2 1.3 Schaffer JN, Pearson MM (2015). "Proteus mirabilis and Urinary Tract Infections". Microbiol Spectr. 3 (5). doi:10.1128/microbiolspec.UTI-0017-2013. PMC 4638163. PMID 26542036.
  2. 2.0 2.1 Coker C, Poore CA, Li X, Mobley HL (2000). "Pathogenesis of Proteus mirabilis urinary tract infection". Microbes Infect. 2 (12): 1497–505. PMID 11099936.
  3. 3.0 3.1 Griffith DP, Musher DM, Itin C (1976). "Urease. The primary cause of infection-induced urinary stones". Invest Urol. 13 (5): 346–50. PMID 815197.
  4. 4.0 4.1 Mobley HL, Island MD, Hausinger RP (1995). "Molecular biology of microbial ureases". Microbiol Rev. 59 (3): 451–80. PMC 239369. PMID 7565414.
  5. 5.0 5.1 Dumanski AJ, Hedelin H, Edin-Liljegren A, Beauchemin D, McLean RJ (1994). "Unique ability of the Proteus mirabilis capsule to enhance mineral growth in infectious urinary calculi". Infect Immun. 62 (7): 2998–3003. PMC 302911. PMID 8005688.